Literature DB >> 32748327

The Effect of Antimicrobial Peptides on the Viability of Human Corneal Epithelial Cells.

Ezgi Ulkuseven1, David J McCanna2, Lakshman N Subbaraman1, Lyndon W Jones1.   

Abstract

Antimicrobial peptides are polypeptides composed of less than 100 amino acids and are a class of antibiotics with strong activity against some infectious bacteria. This study examined the safety of four chosen antimicrobial peptides using primary human corneal epithelial cells (HCEC) and explored their potential therapeutic use. The efficacy of the peptides was also studied by evaluating the minimum inhibitory concentrations (MIC) against Gram-negative and Gram-positive bacteria. One of the peptides (polymyxin E) was found to have antibacterial efficacy against a common Gram-negative bacterium (MIC 1.56 μg/mL for Pseudomonas aeruginosa), and another one (nisin) was found to have antibacterial efficacy against a common Gram-positive bacterium (MIC 125 μg/mL for Staphylococcus aureus). Metabolic activity and live/dead/apoptotic effects were measured with fluorescent dyes after HCEC were exposed to the peptides for 30 min. Three of the peptides exhibited lower toxicity against HCEC than a currently marketed eye drop product. Regarding both efficacy and safety, two of the peptides (polymyxin E and nisin) were found to have potential use for treating ocular infections.

Entities:  

Keywords:  Antibiotics; Antimicrobial peptides; Cathelicidin; Dermcidin; Nisin; Ocular infection; Polymyxin E complex; Safety; Toxicity

Mesh:

Substances:

Year:  2021        PMID: 32748327     DOI: 10.1007/s12602-020-09692-1

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  33 in total

Review 1.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

2.  Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment.

Authors:  Aileen Sy; Muthiah Srinivasan; Jeena Mascarenhas; Prajna Lalitha; Revathi Rajaraman; Meenakshi Ravindran; Catherine E Oldenburg; Kathryn J Ray; David Glidden; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 3.  Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.

Authors:  Mark D P Willcox
Journal:  Optom Vis Sci       Date:  2007-04       Impact factor: 1.973

Review 4.  Pathogenesis of microbial keratitis.

Authors:  Sahreena Lakhundi; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Microb Pathog       Date:  2016-12-18       Impact factor: 3.738

Review 5.  Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.

Authors:  Mark D P Willcox
Journal:  Clin Exp Optom       Date:  2010-11-17       Impact factor: 2.742

6.  Bacterial keratitis: perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment.

Authors:  Abdullah Al-Mujaini; Nadia Al-Kharusi; Archana Thakral; Upender K Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

7.  Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway.

Authors:  Nan Gao; Ashok Kumar; Jeevan Jyot; Fu-Shin Yu
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

8.  Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors.

Authors:  Bradley D Jett; Michael S Gilmore
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 9.  Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.

Authors:  Margit Mahlapuu; Joakim Håkansson; Lovisa Ringstad; Camilla Björn
Journal:  Front Cell Infect Microbiol       Date:  2016-12-27       Impact factor: 5.293

10.  Staphylococcus aureus keratitis: a review of hospital cases.

Authors:  Sherine Jue Ong; Yhu-Chering Huang; Hsin-Yuan Tan; David H K Ma; Hsin-Chiung Lin; Lung-Kun Yeh; Phil Y F Chen; Hung-Chi Chen; Chih-Chun Chuang; Chee-Jen Chang; Ching-Hsi Hsiao
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.